Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2019 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
The following term was not found in PubMed: Jouljamal
Page 1
Conflict of Interest Disclosures.
Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597.
Global Spine J. 2023.
PMID: 37222100
Free PMC article.
No abstract available.
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents.
Abu-Freha N, Abu-Kosh O, Yardeni D, Ashur Y, Abu-Arar M, Yousef B, Monitin S, Weissmann S, Etzion O.
Abu-Freha N, et al.
Life (Basel). 2023 Sep 5;13(9):1872. doi: 10.3390/life13091872.
Life (Basel). 2023.
PMID: 37763276
Free PMC article.
We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associated with fibrosis regression. Fibroscan() was performed for patients treated with DAAs, at least 3 years post-HCV eradication. ...In …
We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associ …
Item in Clipboard
Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.
Anwar MI, Iqbal M, Yousef MS, Rahman M.
Anwar MI, et al.
Microb Cell Fact. 2013 Nov 16;12:111. doi: 10.1186/1475-2859-12-111.
Microb Cell Fact. 2013.
PMID: 24238670
Free PMC article.
Most of the work carried out in this direction has been focusing mainly on HCV genotype 1. Two direct-acting antiviral agents (DAAs) Telaprevir and Boceprevir are being used against genotype 1a infection in combination therapy with interferon and ribavirin. Unfortunately t …
Most of the work carried out in this direction has been focusing mainly on HCV genotype 1. Two direct-acting antiviral agents (DAAs) …
Item in Clipboard
Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis.
Ismail WA, Yousef AE.
Ismail WA, et al.
Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1025-1029. doi: 10.1097/MEG.0000000000001370.
Eur J Gastroenterol Hepatol. 2019.
PMID: 30702448
We evaluated the outcome of treatment with direct-acting antiviral agents (DAAs) on patients with psoriasis having chronic hepatitis C (CHC) infection. ...Future large series studies are needed to evaluate this promising effect of DAAs....
We evaluated the outcome of treatment with direct-acting antiviral agents (DAAs) on patients with psoriasis having chronic hepatitis …
Item in Clipboard
Cite
Cite